Sign in

NCT05286879Completed

Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations

Source: ClinicalTrials.gov · Last updated 21 Sept 2026

Brief summary (registry, in English)

This is a 5-year Hybrid Type 1 Effectiveness-Implementation Randomized Control Trial (RCT) that compares two models of linking and retaining individuals recently released from justice involvement to the continuum of community-based HIV prevention and treatment, HCV treatment, STI treatment, and opioid use disorder (OUD) prevention and treatment, medication for opioid use disorder (MOUD) service cascades of care.

Status (registry)
Completed
Study type
Interventional
Enrollment
601 (actual)
First submitted
25 Feb 2022
Start date
31 Mar 2022
Primary completion date
31 Jul 2025
Lead sponsor
Yale University
NCT number
NCT05286879

What you commit to

  • Study type: Interventional
  • Participants enrolled: 601
  • From 31 Mar 2022 to the primary completion date, 31 Jul 2025
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe medical or psychiatric disability making participation unsafe

Other

  • Unable to provide consent
  • Not remaining in the local area after release from custody
  • Being released to inpatient care
  • Potential risk to research staff

Who the study is looking for

  • Living in one of our research areas
  • Age 18 or older
  • Able to provide written informed consent in English or Spanish
  • Involvement with the criminal justice system within the last 6 months
  • Living with HIV or being at risk of acquiring HIV and willing to learn about PrEP
  • Willing to be tested for HIV (unless already confirmed via medical record)
  • Having a history of opioid and/or stimulant use within 12 months prior to being in a controlled setting and/or in the last 6 months within the community
  • Having a history of condomless sexual intercourse, STI diagnosis, and/or IDU within 6 months prior to being in a controlled setting and/or in the last 6 months within the community

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
UT Southwestern
Coordinator of this site? Confirm its status
DallasUnited StatesUnknown status
Texas Christian University
Coordinator of this site? Confirm its status
Fort WorthUnited StatesUnknown status
Yale School of Medicine
Coordinator of this site? Confirm its status
New HavenUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.